AccuStem

AccuStem Sciences, Inc is a clinical-stage diagnostics company. The company is focused on developing and commercializing novel products for the treatment and management of all cancers. AccuStem Sciences aims to provide a suite of diagnostic tools. These tools are designed to optimize outcomes and quality of life for patients along the continuum of oncology care, from cancer screening through treatment and monitoring. The company operates in the healthcare, pharmaceuticals, diagnostics, and biotechnology industries. AccuStem Sciences, Inc has offices located at 14-15 Conduit Street, London, W1S 2XJ, and 107 Cheapside, 9th Floor, London, X0 EC2V 6DN. The company's Chief Executive Officer is Wendy Blosser, and Jeff Fensterer serves as the Chief Operating Officer. Keeren Shah is the Chief Finance Officer, and Joe Flanagan is the Chief Business Officer. The company's competitive advantages include 25 years of sales excellence experience, 20 years of leadership roles in Finance, and 20 years of experience with start-ups. AccuStem Sciences also focuses on leveraging novel pathways and biomarkers. The company's values include innovation, optimizing outcomes for patients, a holistic approach to oncology care, and a commitment to developing best-in-class products. AccuStem Sciences, Inc utilizes technologies such as SVG, WordPress, Shopify, CloudFlare, and Google Analytics. The company's email address for privacy inquiries is [email protected].